Refractory chronic migraine: is drug withdrawal necessary before starting a therapy with onabotulinum toxin type A?
Crossref DOI link: https://doi.org/10.1007/s10072-016-2662-2
Published Online: 2016-07-09
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Butera, Calogera https://orcid.org/0000-0003-2911-5525
Colombo, Bruno
Bianchi, Francesca
Cursi, Marco
Messina, Roberta
Amadio, Stefano
Guerriero, Roberta
Comi, Giancarlo
Del Carro, Ubaldo
License valid from 2016-07-09